Limitations, agreements, and source contact

Brentuximab Vedotin in Relapsed/Refractory Germ Cell Tumors · Source last updated 2019-12-10

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement

pi Sponsor Employee

true

point Of Contact

email

nadra@iu.edu

organization

IndianaU

phone

(317) 944-5349

title

Dr. Nabil Adra

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice